About
Arfolitixorin
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
8
As Collaborator
1
Total Enrollment
908
By Phase
PHASE1/PHASE2: 6PHASE3: 1PHASE1: 1
By Status
COMPLETED: 7RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT06922383Lead Sponsor
A Clinical Study of Arfolitixorin in Patients With mCRC
PHASE1/PHASE2Recruiting
60 participants
Started: Apr 10, 2025 · Completed: Mar 31, 2029
NCT04126655Collaborator
Modelle 001, TS-inhibition in Colorectal Liver Metastases Comparing Arfolitixorin and Calciumfolinate
PHASE1/PHASE2Unknown
30 participants
Started: Feb 5, 2020 · Completed: Nov 30, 2021
NCT03750786Lead Sponsor
A Study to Compare the Efficacy of Arfolitixorin Versus Leucovorin in Combination With 5 Fluorouracil, Oxaliplatin, and Bevacizumab in Patients With Advanced Colorectal Cancer
PHASE3Completed
490 participants
Started: Dec 18, 2018 · Completed: Nov 18, 2022
NCT03203564Lead Sponsor
Study Evaluating ECG Effects, Safety, Tolerability and Pharmacokinetics of Single Doses of Modufolin (Arfolitixorin) in Healthy Volunteers Tetrahydrofolate in Healthy Male Volunteers
PHASE1Completed
33 participants
Started: Jul 4, 2017 · Completed: Aug 25, 2017
NCT02244632Lead Sponsor
Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer
PHASE1/PHASE2Completed
105 participants
Started: Sep 30, 2014 · Completed: Jan 30, 2020
Locations (1)
Headquarters
Gothenburg, Sweden
Map
Loading map...